MENU
+Compare
SRTS
Stock ticker: NASDAQ
AS OF
Dec 26, 04:51 PM (EDT)
Price
$3.74
Change
-$0.05 (-1.32%)
Capitalization
62.25M

SRTS Sensus Healthcare Forecast, Technical & Fundamental Analysis

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system... Show more

SRTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SRTS with price predictions
Dec 24, 2025

SRTS in +6.10% Uptrend, rising for three consecutive days on December 10, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SRTS advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where SRTS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

SRTS moved above its 50-day moving average on December 16, 2025 date and that indicates a change from a downward trend to an upward trend.

SRTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SRTS as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SRTS turned negative on November 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SRTS entered a downward trend on December 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.216) is normal, around the industry mean (63.841). P/E Ratio (31.500) is within average values for comparable stocks, (37.253). SRTS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). SRTS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (1.741) is also within normal values, averaging (36.935).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SRTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SRTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SRTS is expected to report earnings to fall 27.83% to -4 cents per share on February 05

Sensus Healthcare SRTS Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Beat
by $0.02
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.02
The last earnings report on November 06 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 15.11K shares outstanding, the current market capitalization sits at 62.25M.
A.I. Advisor
published General Information

General Information

a manufacturer of skin cancer treatment products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
851 Broken Sound Parkway, NW
Phone
+1 561 922-5808
Employees
35
Web
https://www.sensushealthcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFWFF3.040.03
+1.00%
Calfrac Well Services Ltd.
ECLMF0.13N/A
N/A
Ecolomondo Corp.
IBIDF81.00N/A
N/A
Ibiden Co. Ltd.
MRPZF11.10N/A
N/A
Mr. Price Group Ltd.
TNCAF14.05N/A
N/A
TC Energy Corp.

SRTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
N/A
LUNG - SRTS
57%
Loosely correlated
+2.70%
VAPO - SRTS
35%
Loosely correlated
N/A
HOLX - SRTS
28%
Poorly correlated
-0.49%
MTD - SRTS
28%
Poorly correlated
+0.18%
PLSE - SRTS
27%
Poorly correlated
+1.92%
More

Groups containing SRTS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
N/A
Medical/Nursing Services
industry (213 stocks)
22%
Poorly correlated
+0.01%
Health Services
industry (403 stocks)
3%
Poorly correlated
+0.00%